The big health-policy debates roiling Washington are still up in the air, but it’s already clear who the big winners are: Lobbyists.
The pharmaceutical industry spent $168 million on lobbying last year, up 32% from the year before, says a report out today from the nonprofit Center for Public Integrity. Over the past decade, the drug [...]
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment